Skip to main content
Premium Trial:

Request an Annual Quote

Nuclea Biotechnologies Expands Office Space, Launches Research Partnership

Premium

Nuclea Biotechnologies this week opened a new bioinformatics and imaging center and launched a partnership with Massachusetts College of Liberal Arts that will focus on developing a bioinformatics research program at the school.

Pittsfield, Mass.-based Nuclea has relocated its data center to a 1,700-square-foot space leased from the Pittsfield Economic Development Authority at the William Stanley Business Park. The company also extended high fiber broadband internet to the site.

Its partnership with MCLA is intended to bring together students with a strong interest in bioinformatics and faculty members to pursue research projects and student internships.

MCLA is one of three institutions — Berkshire Community College and Clark University were the two others —selected by Nuclea last year to house compute clusters that would be used to analyze complex mathematical, biological, and chemical information (BI 4/8/2011).

Last summer, Nuclea said that it would use the cluster it installed at Clark University to support a proteomic and metabolic center that would enable researchers to analyze, identify, and quantify molecular targets as part of their biomedical research, clinical diagnostic discovery, and drug development efforts (BI 7/15/2011).

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.